NRG 200 Pharmacology for Human Caring Nursing - Final
Exam Prep Document | 2026/2027 Edition | 200 Verified
Questions
NRG 200 Pharmacology for Human Caring Nursing Final Exam 2026-2027 QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document contains 200 multiple-choice questions with correct
answers and detailed explanations in italics, specifically designed for the NRG 200 Pharmacology for
Human Caring Nursing final exam. Covering essential pharmacological principles, drug classifications,
nursing implications, and patient education, this resource ensures a thorough review of the curriculum.
Each question is verified for accuracy and aligned with the latest nursing standards and guidelines.
Ideal for nursing students seeking to excel in their pharmacology final examination.
Key Features:
Pharmacokinetics and pharmacodynamics
Drug classifications and mechanisms of action
Nursing process and medication administration
Patient safety and adverse effects monitoring
Special populations and cultural considerations
Legal and ethical aspects of pharmacology
Updates for 2026:
- Revised to reflect the 2026-2027 academic year standards
- Incorporated latest FDA drug approvals and safety alerts
- Updated rationales to align with current evidence-based practice
- Enhanced explanations for high-yield pharmacology topics
- Added new questions on emerging drug therapies
Abstract:
This meticulously curated exam preparation guide for NRG 200 Pharmacology for Human Caring Nursing offers a
robust collection of 200 multiple-choice questions, each accompanied by the correct answer and a comprehensive
explanation in italics. The content is systematically organized to cover all major areas of pharmacology, including
drug classifications, mechanisms of action, therapeutic uses, adverse effects, and nursing considerations. Emphasis
is placed on the application of pharmacological knowledge within the context of human caring, integrating
patient-centered care, safety, and ethical practice. The questions are designed to mirror the format and difficulty of
the actual final exam, providing students with an authentic practice experience. Detailed rationales not only
explain why the correct answer is right but also why the distractors are incorrect, reinforcing critical thinking and
clinical reasoning. This document serves as an indispensable tool for nursing students aiming to achieve a high
level of proficiency in pharmacology and to pass the final exam with confidence.
Keywords:
Pharmacology, Nursing, Human Caring, Final Exam, Multiple Choice Questions, NCLEX-style, Drug
Classifications, Nursing Implications
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed explanation in italics that clarifies the rationale. Explanations also address why the incorrect
options are not the best choices, enhancing understanding of the subject matter.
Page 1
,Compliance Checklist:
All questions align with the NRG 200 course objectives
Rationales are evidence-based and referenced to standard pharmacology texts
Content reflects the latest nursing practice guidelines and safety standards
Questions are formatted to match the style of the actual final exam
Each question has been verified for accuracy and clarity
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-30 Absorption, Distribution, Metabolism, 15%
Pharmacodynamics Excretion, Receptor Theory, Dose-Response
Autonomic Nervous System 31-60 Cholinergics, Anticholinergics, Adrenergics, 15%
Drugs Adrenergic Blockers
Cardiovascular and Renal Drugs 61-90 Antihypertensives, Diuretics, Cardiac 15%
Glycosides, Antiarrhythmics,
Anticoagulants
Central Nervous System Drugs 91-120 Sedatives-Hypnotics, Antidepressants, 15%
Antipsychotics, Antiepileptics, Opioids
Endocrine and Metabolic Drugs 121-150 Insulin, Oral Hypoglycemics, Thyroid 15%
Hormones, Corticosteroids, Sex Hormones
Antimicrobial and 151-180 Antibiotics, Antivirals, Antifungals, 15%
Anti-inflammatory Drugs NSAIDs, Disease-Modifying Antirheumatic
Drugs
Special Populations and Nursing 181-200 Pediatrics, Geriatrics, Pregnancy, Cultural 10%
Considerations Considerations, Patient Education
Page 2
,Q1. A patient on long-term warfarin therapy presents with an INR of 5.8 and no
bleeding. Which intervention is most appropriate?
A. Hold warfarin and administer oral vitamin K 2.5 mg
B. Administer fresh frozen plasma immediately
C. Increase the warfarin dose to correct the INR
D. Administer protamine sulfate intravenously
Correct Answer: A. Hold warfarin and administer oral vitamin K 2.5 mg
Rationale: For an INR >5.0 without major bleeding, the standard of care is to hold
warfarin and give low-dose oral vitamin K (1-5 mg) to reduce bleeding risk. FFP is
reserved for serious bleeding. Increasing warfarin would worsen the INR. Protamine is the
antidote for heparin, not warfarin.
Why Wrong:
B - FFP is indicated for life-threatening bleeding, not for an asymptomatic elevated
INR.
C - Increasing the warfarin dose would further elevate the INR and increase bleeding
risk.
D - Protamine sulfate reverses heparin, not warfarin; it has no effect on vitamin
K-dependent clotting factors.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 34
Q2. Which pharmacodynamic principle best explains why a drug with a high
therapeutic index is generally preferred in clinical practice?
A. It requires lower doses to achieve the same effect
B. It has a wider margin between effective and toxic concentrations
C. It is metabolized more slowly, prolonging its duration of action
D. It produces fewer drug-drug interactions
Correct Answer: B. It has a wider margin between effective and toxic concentrations
Rationale: The therapeutic index is the ratio of the median lethal dose (or toxic dose) to
the median effective dose. A high therapeutic index indicates a wide safety margin between
the dose that produces the desired effect and the dose that causes toxicity, making the drug
safer to use.
Why Wrong:
A - Dose requirement is not directly related to therapeutic index; a high TI drug may
still need high doses.
C - Metabolism rate affects duration, not the safety margin between effective and
toxic doses.
D - Drug interactions are independent of the therapeutic index.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 3
Page 3
, Q3. A patient with type 2 diabetes is prescribed metformin. Which laboratory value
requires immediate assessment to minimize the risk of a serious adverse effect?
A. Serum creatinine
B. Aspartate aminotransferase (AST)
C. Complete blood count (CBC)
D. Thyroid-stimulating hormone (TSH)
Correct Answer: A. Serum creatinine
Rationale: Metformin is contraindicated in patients with significant renal impairment
because it accumulates and increases the risk of lactic acidosis, a potentially fatal adverse
effect. Serum creatinine is used to estimate renal function (eGFR) before and during
therapy.
Why Wrong:
B - Metformin is not hepatotoxic; liver enzymes are not the primary monitoring
parameter.
C - Metformin does not typically affect blood counts.
D - Metformin does not affect thyroid function.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 59
Q4. A patient receiving morphine for severe pain develops respiratory depression.
Which agent should be administered to reverse this effect?
A. Flumazenil
B. Naloxone
C. Naltrexone
D. Acetylcysteine
Correct Answer: B. Naloxone
Rationale: Naloxone is a competitive opioid receptor antagonist that rapidly reverses
opioid-induced respiratory depression. Flumazenil reverses benzodiazepines, naltrexone is
used for alcohol/opioid maintenance, and acetylcysteine is for acetaminophen overdose.
Why Wrong:
A - Flumazenil is the antidote for benzodiazepine overdose, not opioids.
C - Naltrexone is used for long-term management of opioid dependence, not acute
reversal.
D - Acetylcysteine is used for acetaminophen toxicity.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 19
Q5. A patient on digoxin develops nausea, visual disturbances, and bradycardia.
Which laboratory value is most likely to confirm toxicity?
A. Serum potassium level
B. Serum digoxin level
Page 4
Exam Prep Document | 2026/2027 Edition | 200 Verified
Questions
NRG 200 Pharmacology for Human Caring Nursing Final Exam 2026-2027 QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document contains 200 multiple-choice questions with correct
answers and detailed explanations in italics, specifically designed for the NRG 200 Pharmacology for
Human Caring Nursing final exam. Covering essential pharmacological principles, drug classifications,
nursing implications, and patient education, this resource ensures a thorough review of the curriculum.
Each question is verified for accuracy and aligned with the latest nursing standards and guidelines.
Ideal for nursing students seeking to excel in their pharmacology final examination.
Key Features:
Pharmacokinetics and pharmacodynamics
Drug classifications and mechanisms of action
Nursing process and medication administration
Patient safety and adverse effects monitoring
Special populations and cultural considerations
Legal and ethical aspects of pharmacology
Updates for 2026:
- Revised to reflect the 2026-2027 academic year standards
- Incorporated latest FDA drug approvals and safety alerts
- Updated rationales to align with current evidence-based practice
- Enhanced explanations for high-yield pharmacology topics
- Added new questions on emerging drug therapies
Abstract:
This meticulously curated exam preparation guide for NRG 200 Pharmacology for Human Caring Nursing offers a
robust collection of 200 multiple-choice questions, each accompanied by the correct answer and a comprehensive
explanation in italics. The content is systematically organized to cover all major areas of pharmacology, including
drug classifications, mechanisms of action, therapeutic uses, adverse effects, and nursing considerations. Emphasis
is placed on the application of pharmacological knowledge within the context of human caring, integrating
patient-centered care, safety, and ethical practice. The questions are designed to mirror the format and difficulty of
the actual final exam, providing students with an authentic practice experience. Detailed rationales not only
explain why the correct answer is right but also why the distractors are incorrect, reinforcing critical thinking and
clinical reasoning. This document serves as an indispensable tool for nursing students aiming to achieve a high
level of proficiency in pharmacology and to pass the final exam with confidence.
Keywords:
Pharmacology, Nursing, Human Caring, Final Exam, Multiple Choice Questions, NCLEX-style, Drug
Classifications, Nursing Implications
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed explanation in italics that clarifies the rationale. Explanations also address why the incorrect
options are not the best choices, enhancing understanding of the subject matter.
Page 1
,Compliance Checklist:
All questions align with the NRG 200 course objectives
Rationales are evidence-based and referenced to standard pharmacology texts
Content reflects the latest nursing practice guidelines and safety standards
Questions are formatted to match the style of the actual final exam
Each question has been verified for accuracy and clarity
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-30 Absorption, Distribution, Metabolism, 15%
Pharmacodynamics Excretion, Receptor Theory, Dose-Response
Autonomic Nervous System 31-60 Cholinergics, Anticholinergics, Adrenergics, 15%
Drugs Adrenergic Blockers
Cardiovascular and Renal Drugs 61-90 Antihypertensives, Diuretics, Cardiac 15%
Glycosides, Antiarrhythmics,
Anticoagulants
Central Nervous System Drugs 91-120 Sedatives-Hypnotics, Antidepressants, 15%
Antipsychotics, Antiepileptics, Opioids
Endocrine and Metabolic Drugs 121-150 Insulin, Oral Hypoglycemics, Thyroid 15%
Hormones, Corticosteroids, Sex Hormones
Antimicrobial and 151-180 Antibiotics, Antivirals, Antifungals, 15%
Anti-inflammatory Drugs NSAIDs, Disease-Modifying Antirheumatic
Drugs
Special Populations and Nursing 181-200 Pediatrics, Geriatrics, Pregnancy, Cultural 10%
Considerations Considerations, Patient Education
Page 2
,Q1. A patient on long-term warfarin therapy presents with an INR of 5.8 and no
bleeding. Which intervention is most appropriate?
A. Hold warfarin and administer oral vitamin K 2.5 mg
B. Administer fresh frozen plasma immediately
C. Increase the warfarin dose to correct the INR
D. Administer protamine sulfate intravenously
Correct Answer: A. Hold warfarin and administer oral vitamin K 2.5 mg
Rationale: For an INR >5.0 without major bleeding, the standard of care is to hold
warfarin and give low-dose oral vitamin K (1-5 mg) to reduce bleeding risk. FFP is
reserved for serious bleeding. Increasing warfarin would worsen the INR. Protamine is the
antidote for heparin, not warfarin.
Why Wrong:
B - FFP is indicated for life-threatening bleeding, not for an asymptomatic elevated
INR.
C - Increasing the warfarin dose would further elevate the INR and increase bleeding
risk.
D - Protamine sulfate reverses heparin, not warfarin; it has no effect on vitamin
K-dependent clotting factors.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 34
Q2. Which pharmacodynamic principle best explains why a drug with a high
therapeutic index is generally preferred in clinical practice?
A. It requires lower doses to achieve the same effect
B. It has a wider margin between effective and toxic concentrations
C. It is metabolized more slowly, prolonging its duration of action
D. It produces fewer drug-drug interactions
Correct Answer: B. It has a wider margin between effective and toxic concentrations
Rationale: The therapeutic index is the ratio of the median lethal dose (or toxic dose) to
the median effective dose. A high therapeutic index indicates a wide safety margin between
the dose that produces the desired effect and the dose that causes toxicity, making the drug
safer to use.
Why Wrong:
A - Dose requirement is not directly related to therapeutic index; a high TI drug may
still need high doses.
C - Metabolism rate affects duration, not the safety margin between effective and
toxic doses.
D - Drug interactions are independent of the therapeutic index.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 3
Page 3
, Q3. A patient with type 2 diabetes is prescribed metformin. Which laboratory value
requires immediate assessment to minimize the risk of a serious adverse effect?
A. Serum creatinine
B. Aspartate aminotransferase (AST)
C. Complete blood count (CBC)
D. Thyroid-stimulating hormone (TSH)
Correct Answer: A. Serum creatinine
Rationale: Metformin is contraindicated in patients with significant renal impairment
because it accumulates and increases the risk of lactic acidosis, a potentially fatal adverse
effect. Serum creatinine is used to estimate renal function (eGFR) before and during
therapy.
Why Wrong:
B - Metformin is not hepatotoxic; liver enzymes are not the primary monitoring
parameter.
C - Metformin does not typically affect blood counts.
D - Metformin does not affect thyroid function.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 59
Q4. A patient receiving morphine for severe pain develops respiratory depression.
Which agent should be administered to reverse this effect?
A. Flumazenil
B. Naloxone
C. Naltrexone
D. Acetylcysteine
Correct Answer: B. Naloxone
Rationale: Naloxone is a competitive opioid receptor antagonist that rapidly reverses
opioid-induced respiratory depression. Flumazenil reverses benzodiazepines, naltrexone is
used for alcohol/opioid maintenance, and acetylcysteine is for acetaminophen overdose.
Why Wrong:
A - Flumazenil is the antidote for benzodiazepine overdose, not opioids.
C - Naltrexone is used for long-term management of opioid dependence, not acute
reversal.
D - Acetylcysteine is used for acetaminophen toxicity.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 19
Q5. A patient on digoxin develops nausea, visual disturbances, and bradycardia.
Which laboratory value is most likely to confirm toxicity?
A. Serum potassium level
B. Serum digoxin level
Page 4
